Assignee
NUO BETA PHARMACEUTICAL TECH SHANGHAI CO LTD
CN·0 granted patents·4 pending applications·0 citations·filing 2021–2022
Top patents by PatentIndex Score
4 records- 0153US2024050395A1Deuterated oxophenylarsine compound and use thereofNUO BETA PHARMACEUTICAL TECH SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 0253US2024391942A1Halogenated phenylarsine oxide compound and application thereofNUO BETA PHARMACEUTICAL TECH SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0349US2024261250A1Applications of p14k inhibitor in intracellular protein misfolding-related diseases and lysosomal storage diseasesNUO BETA PHARMACEUTICAL TECH SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 0442US2025152599A1Anti-coronavirus effect and application of p14k inhibitorNUO BETA PHARMACEUTICAL TECH SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NUO BETA PHARMACEUTICAL TECH SHANGHAI CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →